IFIH1 and dermatomyositis: It is necessary to dissect the linking of tendency between type I IFN response and anti-MDA5 antibodies, as these may provide a context for the investigation into the underlying mechanisms of MDA5+ DM, a serologically-defined disease, and offer promising targets and a well-placed therapeutic window.